Celia Witten

Vericel Corp (NASDAQ: VCEL), a nano-cap commercial-stage biopharmaceutical company that focuses on therapies which enable the body to repair and regenerate damaged tissues and organs, soared by more than 50 percent Tuesday morning. Vericel is currently developing MACI, a third-generation...